The present invention relates to stable pharmaceutical compositions comprising linaclotide or pharmaceutically acceptable salts thereof, as well as to various methods and processes for the preparation and use of the compositions.L'invention se rapporte à des compositions pharmaceutiques stables renfermant du linaclotide ou des sels pharmaceutiquement acceptables de ce dernier, et à divers procédés de préparation et d'utilisation desdites compositions.
